homocysteine has been researched along with Venous Thrombosis in 122 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (14.75) | 18.2507 |
2000's | 81 (66.39) | 29.6817 |
2010's | 20 (16.39) | 24.3611 |
2020's | 3 (2.46) | 2.80 |
Authors | Studies |
---|---|
Abdullah, SM; Akhter, MS; Biswas, A; Dobie, G; Hamali, HA; Iqbal, J; Mobarki, AA; Saxena, R | 1 |
Ames, PRJ; Arcaro, A; D'Andrea, G; Gentile, F; Iannaccone, L; Maraglione, M; Marottoli, V | 1 |
Shi, B; Zhang, M; Zhao, M | 1 |
Moiz, B | 1 |
Chang, YW; Li, ZF; Liu, SY; Shu, XJ; Wang, WH | 1 |
Ci, H; Ge, X; Song, W; Tian, G; Zhang, Y | 1 |
Cannegieter, SC; Hensen, ADO; Lijfering, WM; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
Cabarkapa, VS; Ilic, TA; Lozanov-Crvenkovic, ZS; Mitic, GP; Salatic, IR; Vuckovic, BA | 1 |
Ali, Z; Fowler, DR; Troncoso, JC | 1 |
Ghaznavi, H; Samiei, S; Soheili, Z; Soltanpour, MS | 1 |
Chang, HG; Ji, SB; Ma, PJ; Su, LL; Tao, SB; Wang, CW | 1 |
Chae, H; Kim, H; Kim, M; Kim, Y; Lee, GD; Lee, JM; Lee, SY; Oh, YS; Park, J | 1 |
Cuoghi, C; Fiorini, M; Marcacci, M; Marchini, S; Pietrangelo, A; Ventura, P; Venturelli, G | 1 |
Cass, A; Gallagher, MP; Jardine, MJ; Kang, A; Kulshrestha, S; Navaneethan, SD; Nigwekar, SU; Perkovic, V; Strippoli, GF; Zoungas, S | 1 |
Corella, D; Ferrando, F; Gómez, I; Mira, Y; Vayá, A | 1 |
Kalathil, D; Musarrat, K; Varughese, GI | 1 |
Bharatkumar, VP; Christopher, R; Nagaraja, D; Noone, ML | 1 |
Antov, S; Arsov, T; Bosilkova, G; Dzhekova-Stojkova, S; Efinska-Mladenovska, O; Kedev, S; Kostovska, S; Krstevska, M; Petlichkovski, A; Spiroski, I; Spiroski, M; Strezova, A; Trajkov, D | 1 |
Lee, JS; Shin, JI | 1 |
Duan, ZQ; Fan, YY; He, JA; Hu, XH; Liu, CW; Xin, SJ; Yang, DH; Yang, J; Zhang, J; Zhang, Q; Zhang, ZS | 1 |
Alvandfar, D; Ravari, H; Saadat, S; Zafarghandi, MR | 1 |
Dokras, A; Mak, W | 1 |
Aydoğdu, M; Bukan, N; Ekim, N; Kanbay, A; Köktürk, N; Özyılmaz, E | 1 |
Casey, A; Schinzel, H; Walter, PK; Wilmanns, C | 1 |
Bonet, E; Carrasco, P; Morales-Suárez-Varela, MM; Plumé, G; Vayá, A | 1 |
Abraldes, JG; Candusso, M; Luciani, M; Monti, L; Nobili, V; Pancotti, S; Pietrobattista, A; Soldati, M; Torre, G | 1 |
Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
Ben Hamouda, H; Braham, H; Ghanmi, S; Hamza, HA; Hassine, M; Sfar, MT; Soua, H; Wannes, S | 1 |
Ardizzone, S; Bolzacchini, E; de Franchis, R; Dell'Era, A; Maconi, G; Russo, U | 1 |
Cao, Y; Geng, Z; Huang, L; Jiang, L; Liu, Y; Xu, D; Zhao, R; Zhou, J; Zhou, K | 1 |
Adamek, L; Domagala, TB; Nizankowska, E; Sanak, M; Szczeklik, A | 1 |
Gala, JL; Hainaut, P; Heusterspreute, M; Jaumotte, C; Lavenne, E; Moriau, M; Verhelst, D; Wallemacq, P; Zech, F | 1 |
Key, NS; McGlennen, RC | 1 |
Law, M; Morris, JK; Wald, DS | 2 |
Ames, PR; Amitrano, L; Annunziata, M; Antinolfi, I; Balzano, A; Brancaccio, V; Ferrara, F; Guardascione, MA; Iannaccone, L; Margaglione, M | 1 |
Aleksic, N; Cushman, M; Folsom, AR; Heckbert, SR; Psaty, BM; Rosamond, WD; Tsai, AW; Tsai, MY; Yanez, ND | 1 |
Ahmed, R; Choudhry, VP; Gupta, M; Gupta, S; Saxena, R | 1 |
Ridker, PM | 1 |
Blanco-Vaca, F; Cuquet, J; López, N; Mateo, J | 1 |
Arslan, D; Baslamisli, F; Canataroglu, A; Inal, T; Ozbek, S; Seydaoglu, G; Tanriverdi, K | 1 |
Al-Habboubi, H; Almawi, WY; Ameen, G; Tamim, H | 1 |
Harrington, DJ; Kapustin, SI; Papayan, LP; Savidge, GF; Shmeleva, VM; Sobczyńska-Malefora, A | 1 |
Cobelli, M; Marietta, M; Panini, R; Rosa, MC; Salvioli, G; Ventura, P | 1 |
Qiu, L; Song, YH; Yan, SK | 1 |
Hausmann, MJ; Rogachev, B; Tomer, A; Vorobiov, M; Zlotnik, M | 1 |
Blom, HJ; Den Heijer, M; Heil, SG; Kluijtmans, LA; Van Der Rijt-Pisa, BJ | 1 |
Frederiksen, J; Grande, P; Jensen, GB; Juul, K; Nordestgaard, BG; Schroeder, TV; Tybjaerg-Hansen, A | 1 |
Blom, HJ; den Heijer, M; Gellekink, H; Kluijtmans, LA | 1 |
Alexander, M; Gnanamuthu, C; Joseph, M; Vaid, U | 1 |
Han, FL; Li, Q; Wang, MT; Yao, XP | 1 |
Bhat, G; Costea, A | 1 |
Kotel'nikov, MV | 1 |
El Matri, L; Feki, M; Ghannouchi, M; Hamzaoui, K; Houman, H; Kaabachi, N; Mebazaa, A; Smiti-Khanfir, M | 1 |
Bowden, RG; Gentile, M; Wilborn, C; Wilson, R; Wyatt, FB | 1 |
Clarke, R; Den Heijer, M; Lewington, S | 1 |
Muller, AF; Srirajaskanthan, R; Winter, M | 1 |
Bakan, E; Becit, N; Keleş, S; Koçak, H; Koçoğullari, CU; Unlü, Y | 1 |
Dauzat, M; Gris, JC; Quéré, I | 1 |
Caprini, JA; Glase, CJ; Goldshteyn, S; Hathaway, K | 1 |
Belinchón, O; Bruscas, MJ; Cortés, A; Díaz DE Tuesta, AM; Marchena, PJ; Nieto, JA; Ribó, MD; Val, E | 1 |
Barberis, G; Drenkard, C; Gamron, S; Menso, E; Onetti, CM; Onetti, L; Villafañe, S | 1 |
Dávid, M; Habon, T; Keszthelyi, Z; Kovács, N; Losonczy, H; Nagy, A; Tóth, O | 1 |
Eichinger, S | 1 |
den Heijer, M | 1 |
Al Haddabi, H; Al Kindi, S; Bayoumi, R; Dennison, D; Muralitharan, S; Pathare, A | 1 |
Blom, HJ; Borm, GF; den Heijer, M; Keijzer, MB; Verhoef, P | 1 |
Franco, RF; Lourenço, DM; Maffei, FH; Morelli, VM; Pereira, AC; Rollo, HA; Vannucchi, H; Zago, MA | 1 |
Föger, B | 1 |
Cantürk, NZ; Celebi, A; Hülagü, OS; Karakaya, AT; Ozgür, O; Sentürk, O | 1 |
Blom, HJ; Bos, GM; Cattaneo, M; den Heijer, M; Eichinger, S; Gerrits, WB; Rosendaal, FR; Willems, HP | 1 |
Blom, HJ; Borm, GF; den Heijer, M; Hermus, AR; Keijzer, MB; Ueland, PM; Vollset, SE | 1 |
Feki, H; Feki, M; Ghorbel, IB; Houman, H; Kaabachi, N; Omar, S; Souissi, M | 1 |
Cattaneo, M | 2 |
D'Almeida, V; DA Silveira, RC; Lourenço, DM; Morelli, VM; Rodrigues, CA | 1 |
Abdella, N; Al Humood, S; Al Mazeedy, M; Al Wazzan, H; Marouf, R; Mojiminiyi, O; Qurtom, M | 1 |
Brouwer, JL; Lijfering, WM; van de Poel, MH; van der Meer, J; Veeger, NJ | 1 |
Abbate, R; Aito, S; Cominelli, E; Marcucci, R | 1 |
Castañon, MM; Kordich, L; Lauricella, AM; Quintana, I | 1 |
Bezemer, ID; Doggen, CJ; Rosendaal, FR; Vos, HL | 1 |
Goto, K; Hiratsuka, M; Ishii, M; Kanno, J; Kiyoshige, Y; Kure, S | 1 |
Gatt, A; Makris, M | 1 |
Cushman, M | 1 |
Blom, HJ; den Heijer, M; Gellekink, H | 1 |
Abbate, R; Gensini, GF; Gori, AM; Marcucci, R; Sofi, F | 1 |
Ageno, W; Dentali, F; Ghirarduzzi, A; Pesavento, R; Prandoni, P; Romualdi, E | 1 |
Jain Jamal, MN; Naushad, SM; Prasad, CK; Rama Devi, AR | 1 |
Blom, HJ; den Heijer, M; Gellekink, H; Hermus, AR; Muntjewerff, JW; Vermeulen, SH | 1 |
Blom, HJ; Cannegieter, SC; Christiansen, SC; Hammerstrøm, J; Naess, IA; Romundstad, PR; Rosendaal, FR | 1 |
Aydintuğ, OT; Duman, T; Düzgün, N; Ertuğrul, E; Köse, K; Morris, Y; Tutkak, H | 1 |
Bellet, E; Chassé, JF; Dupuy, E; Janbon, C; Molho-Sabatier, P; Quéré, I; Tobelem, G | 1 |
Baker, RI; Eikelboom, JW | 1 |
Arroliga, AC; Marelich, GP; Matthay, RA; Murin, S | 1 |
Coto, E; Pinto, CR; Soto, I; Urgelles, MF; Vargas, M | 1 |
Blom, HJ; Bos, GM; den Heijer, M; Gerrits, WB; Rosendaal, FR | 1 |
Bayle, C; Bellet, H; Caussé, E; Champagne, S; Couderc, F; Salvayre, R; Siri, N; Valdiguié, P | 1 |
Boer, J; Kolbach, DN | 1 |
Bauer, KA; Leonard, DG; Van Deerlin, VM; Wulf, GM | 1 |
Hall, TN; Leahy, MF; Ramakrishnan, LL | 1 |
Blom, HJ; Bos, GM; den Heijer, M; Gerrits, WB; Rosendaal, FR; Willems, HP | 1 |
Aarnoudse, JG; Lubbers, MF; van Doormaal, JJ | 1 |
Donnelly, JG; Rock, GA | 1 |
Ducros, V; Faure, H; Favier, A; Pernod, G; Polack, B; Schmitt, D | 1 |
Cable, GG | 1 |
Bresson-Vautrin, C; Chalopin, JM; Ducloux, D | 1 |
Devaraj, S; Jialal, I; Marangon, K; O'Byrne, D | 1 |
Auberger, K; Homberger, A; Junker, R; Koch, HG; Linnebank, M; Nabel, P; Nowak-Göttl, U; Schobess, R | 1 |
Grigg, AP | 1 |
Bos, GM; den Heijer, M; Willems, HP | 1 |
Aubard, Y; Cantaloube, M; Darodes, N | 1 |
Günther, G; Heller, C; Junker, R; Kreuz, W; Kurnik, K; Nowak-Göttl, U; Schobess, R | 1 |
Aras , O; Hanson, NQ; Tsai, MY; Yang, F | 1 |
Chang, CJ; Chiang, CW; Hsu, LA; Hsu, TS; Ko, YL; Kuo, CT; Lee, YS; Sun, CF | 1 |
Abbate, R; Brunelli, T; Fedi, S; Gensini, GF; Giusti, B; Marcucci, R; Pepe, G; Poli, D; Prisco, D | 1 |
Konetschny, R; Renner, W; Stanger, O; Weger, M | 1 |
Bucciarelli, P; Cattaneo, M; Lecchi, A; Lombardi, R; Mannucci, PM | 1 |
Ames, PR; Cappucci, G; Margaglione, M | 1 |
Cerbone, AM; Cirillo, F; Coppola, A; de Stefano, V; Di Minno, G; Madonna, P; Orefice, G | 1 |
Reitsma, PH; Rosendaal, FR; van Aken, BE | 1 |
Bellet, H; Bounameaux, H; Daurès, JP; Dauzat, M; de Moerloose, P; Gris, JC; Janbon, C; Laroche, JP; Mercier, E; Perneger, TV; Quéré, I; Schved, JF; Zittoun, J | 1 |
Dvorsak, B; Ekart, R; Gorenjak, M; Hojs, R; Pecovnik-Balon, B | 1 |
23 review(s) available for homocysteine and Venous Thrombosis
Article | Year |
---|---|
Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature.
Topics: Heterozygote; Homocysteine; Humans; Intracranial Thrombosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Obesity; Recurrence; Sickle Cell Trait; Venous Thrombosis; Young Adult | 2014 |
Interventions for lowering plasma homocysteine levels in dialysis patients.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Renal Dialysis; Stroke; Venous Thrombosis; Vitamin B 12; Vitamin B 6; Vitamin B Complex | 2016 |
Polycystic ovarian syndrome and the risk of cardiovascular disease and thrombosis.
Topics: Adiponectin; Biomarkers; Blood Coagulation Disorders; Blood Coagulation Factors; C-Reactive Protein; Cardiovascular Diseases; Comorbidity; Contraceptives, Oral, Hormonal; Female; Homocysteine; Humans; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk Factors; Venous Thrombosis | 2009 |
Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.
Topics: Female; Homocysteine; Humans; Male; PubMed; Randomized Controlled Trials as Topic; Risk Factors; Venous Thrombosis; Vitamin B Complex | 2012 |
Hyperhomocyst(e)inemia and Thrombophilia.
Topics: Blood Coagulation Tests; Homocysteine; Humans; Hyperhomocysteinemia; Practice Guidelines as Topic; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thromboembolism; Thrombophilia; Venous Thrombosis | 2002 |
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.
Topics: Cohort Studies; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Myocardial Ischemia; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Prospective Studies; Pulmonary Embolism; Risk Factors; Venous Thrombosis | 2002 |
Inherited risk factors for venous thromboembolism: implications for clinical practice.
Topics: Activated Protein C Resistance; Anticoagulants; Factor V; Homocysteine; Humans; Models, Statistical; Point Mutation; Prevalence; Prothrombin; Recurrence; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening.
Topics: Adult; Homocysteine; Humans; Male; Mass Screening; Middle Aged; Myocardial Ischemia; Venous Thrombosis | 2004 |
[Hyperhomocysteinemia: from theory and practice in the treatment of thrombophilias].
Topics: Administration, Oral; Anticoagulants; Blood Coagulation Tests; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Marfan Syndrome; Multicenter Studies as Topic; Mutation; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Risk Factors; Thrombophilia; Time Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6 | 2004 |
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
Topics: Case-Control Studies; Genotype; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Polymorphism, Single Nucleotide; Risk; Venous Thrombosis | 2005 |
Homocysteine and venous thrombosis.
Topics: Biomarkers; Homocysteine; Homocystinuria; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Polymorphism, Genetic; Risk Factors; Venous Thrombosis | 2005 |
[Type I antithrombin deficiency as a cause of arterial and venous thrombosis in a family with severe thrombophilia].
Topics: Adult; C-Reactive Protein; Cholesterol; Cysteine; Female; Fibrin; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Pedigree; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Risk Factors; Threonine; Thrombophilia; Thrombosis; Venous Thrombosis; von Willebrand Factor | 2005 |
Are B vitamins a risk factor for venous thromboembolism? Yes.
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Recurrence; Risk Factors; Thromboembolism; Venous Thrombosis; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Deficiency | 2006 |
Are B vitamins a risk factor for VTE? Perhaps.
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thromboembolism; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency; Vitamin B 6; Vitamin B 6 Deficiency; Vitamin B Deficiency | 2006 |
Hyperhomocysteinemia and venous thromboembolism.
Topics: Case-Control Studies; Homocysteine; Homocystinuria; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Point Mutation; Prospective Studies; Recurrence; Risk Factors; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamins | 2006 |
Hyperhomocysteinemia and venous thrombosis.
Topics: Female; Homocysteine; Humans; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; Retrospective Studies; Venous Thrombosis | 2007 |
Epidemiology and risk factors for venous thrombosis.
Topics: Age Factors; Homocysteine; Humans; Incidence; Obesity; Pulmonary Embolism; Recurrence; Risk Factors; Venous Thrombosis | 2007 |
Hereditary thrombophilia and venous thromboembolism.
Topics: Antithrombin III Deficiency; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Mutation; Prevalence; Protein C; Protein C Deficiency; Protein S Deficiency; Prothrombin; Thrombophilia; Venous Thrombosis | 1998 |
Hyperhomocysteinemia and venous thrombosis: a meta-analysis.
Topics: Adult; Case-Control Studies; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Odds Ratio; Risk Factors; Venous Thrombosis | 1998 |
[Hyperhomocysteinemia as a risk factor for venous thrombosis].
Topics: Adult; Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prospective Studies; Pyridoxine; Randomized Controlled Trials as Topic; Venous Thrombosis; Vitamin B 12 | 1999 |
Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications.
Topics: Abortion, Habitual; Anticoagulants; Female; Fetal Death; Fetal Growth Retardation; Homocysteine; Humans; Neural Tube Defects; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Venous Thrombosis | 2000 |
Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
Topics: Endothelium, Vascular; Free Radicals; Homocysteine; Humans; Hyperhomocysteinemia; Methionine; Models, Biological; Models, Chemical; Oxidative Stress; Vascular Diseases; Venous Thrombosis | 2001 |
Hyperhomocysteinemia and thrombosis.
Topics: Animals; Arteriosclerosis; Case-Control Studies; Cross-Sectional Studies; Homocysteine; Humans; Hyperhomocysteinemia; Risk Factors; Thrombosis; Venous Thrombosis | 2001 |
7 trial(s) available for homocysteine and Venous Thrombosis
Article | Year |
---|---|
Effects of folic acid combined with vitamin B12 on DVT in patients with homocysteine cerebral infarction.
Topics: Adult; Aged; Cerebral Infarction; Drug Therapy, Combination; Female; Folic Acid; Homocysteine; Humans; International Normalized Ratio; Male; Middle Aged; Recurrence; Venous Thrombosis; Vitamin B 12 | 2017 |
Hyperhomocysteinaemia and the risk of recurrent venous thrombosis: results from the MEGA follow-up study.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Recurrence; Risk Factors; Venous Thrombosis | 2019 |
Hyperhomocysteinemia prevalence among patients with venous thromboembolism.
Topics: Adult; Aged; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Risk Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency | 2011 |
Effect of Helicobacter pylori infection on deep vein thrombosis seen in patients with Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Case-Control Studies; Female; Helicobacter Infections; Helicobacter pylori; Homocysteine; Hospitals, Teaching; Humans; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Venous Thrombosis | 2006 |
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Proportional Hazards Models; Pulmonary Embolism; Pyridoxine; Recurrence; Risk Factors; Thrombophilia; Treatment Failure; Venous Thrombosis; Vitamin B 12 | 2007 |
Homocysteine reduction by B-vitamin supplementation increases t-PA and PAI-1 levels in patients with venous thromboembolism.
Topics: Adolescent; Adult; Aged; Dietary Supplements; Double-Blind Method; Drug Combinations; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Pulmonary Embolism; Pyridoxine; Time Factors; Tissue Plasminogen Activator; Treatment Outcome; Venous Thrombosis; Vitamin B 12; Vitamin B Complex | 2007 |
Homocysteine and venous thrombosis: outline of a vitamin intervention trial.
Topics: Adult; Aged; Aged, 80 and over; Comorbidity; Double-Blind Method; Female; Folic Acid; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Middle Aged; Netherlands; Prospective Studies; Pulmonary Embolism; Pyridoxine; Retrospective Studies; Secondary Prevention; Thrombophilia; Thrombophlebitis; Treatment Outcome; Ultrasonography; Venous Thrombosis; Vitamin B 12 | 2000 |
92 other study(ies) available for homocysteine and Venous Thrombosis
Article | Year |
---|---|
Endothelial Nitric Oxide Synthase Gene Polymorphisms Increase Risk of Deep Vein Thrombosis by Altering Homocysteine Levels.
Topics: Adolescent; Adult; Genotype; Homocysteine; Humans; Middle Aged; Nitric Oxide; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Venous Thrombosis; Young Adult | 2022 |
Liver Cirrhosis Patients Homozygous for MTHFR C677T Develop Portal Vein Thrombosis 8 Years Earlier Than Wild Type.
Topics: Aged; Cross-Sectional Studies; Genotype; Homocysteine; Humans; Liver Cirrhosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Portal Vein; Protein C; Retrospective Studies; Venous Thrombosis | 2023 |
Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report.
Topics: Adolescent; Female; Folic Acid; Genotype; Heterozygote; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Loss of Heterozygosity; Methylenetetrahydrofolate Reductase (NADPH2); Venous Thrombosis | 2023 |
Homocysteine as a Biomarker for Thrombosis: What is the Learning Curve?
Topics: Biomarkers; Homocysteine; Humans; Learning Curve; Venous Thrombosis | 2017 |
Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.
Topics: Animals; Anticoagulants; Chlorides; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Endothelial Cells; Ferric Compounds; Gene Expression Regulation; Homocysteine; Hydrogen Sulfide; Male; Matrix Metalloproteinase 9; Phosphatidylinositol 3-Kinases; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Thiazoles; Venous Thrombosis | 2017 |
Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients.
Topics: Adolescent; Adult; Case-Control Studies; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Risk Factors; Venous Thrombosis; Young Adult | 2013 |
Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population.
Topics: Adolescent; Adult; Aged; Alleles; Case-Control Studies; Fasting; Female; Gene Expression; Genetic Association Studies; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Risk Factors; Venous Thrombosis | 2015 |
An Increased Serum Level of Lipoprotein(a) Is a Predictor for Deep Vein Thrombosis in Patients with Spinal Cord Injuries.
Topics: Adult; Asian People; Biomarkers; C-Reactive Protein; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Lipoprotein(a); Male; Middle Aged; Prospective Studies; Risk Factors; Spinal Cord Injuries; Ultrasonography, Doppler, Color; Venous Thrombosis | 2016 |
Potential Risk Factors Associated With Vascular Diseases in Patients Receiving Treatment for Hypertension.
Topics: Adult; Aged; Antihypertensive Agents; DNA; Factor V; Female; Fibrin Fibrinogen Degradation Products; Genotype; Homocysteine; Humans; Hypertension; Lipids; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Platelet Count; Polymorphism, Single Nucleotide; Prothrombin; Real-Time Polymerase Chain Reaction; Republic of Korea; Risk Factors; Vascular Diseases; Venous Thrombosis | 2016 |
Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.
Topics: Aged; Carcinoma, Hepatocellular; Female; Homocysteine; Humans; Hyperhomocysteinemia; Liver Cirrhosis; Liver Neoplasms; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Portal Vein; Retrospective Studies; Venous Thrombosis | 2016 |
Homocysteine levels in patients with deep vein thrombosis lacking thrombophilic defects.
Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk Assessment; Risk Factors; Thrombophilia; Venous Thrombosis | 2008 |
Metformin, B12 and homocysteine levels: the plausible cause or effect?
Topics: Homocysteine; Humans; Hyperhomocysteinemia; Metformin; Venous Thrombosis; Vitamin B 12; Vitamin B 12 Deficiency | 2008 |
Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis.
Topics: Adolescent; Adult; Confidence Intervals; Female; Folic Acid; Homocysteine; Humans; Intracranial Thrombosis; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Prothrombin; Puerperal Disorders; Risk; Risk Assessment; Statistics as Topic; Venous Thrombosis; Vitamin B 12 | 2008 |
Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
Topics: Adult; Aged; Arterial Occlusive Diseases; Case-Control Studies; Female; Genotype; Haplotypes; Heterozygote; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Republic of North Macedonia; Venous Thrombosis | 2008 |
High factor VIII or homocysteine levels and thrombosis in Henoch-Schönlein purpura.
Topics: Adolescent; Biomarkers; Coagulation Protein Disorders; Factor VIII; Homocysteine; Humans; IgA Vasculitis; Male; Venous Thrombosis; von Willebrand Factor | 2009 |
Hyperhomocysteinaemia, low folate concentrations and methylene tetrahydrofolate reductase C677T mutation in acute mesenteric venous thrombosis.
Topics: Acute Disease; Adult; Aged; Asian People; Biomarkers; Case-Control Studies; Chi-Square Distribution; China; Chromatography, High Pressure Liquid; Down-Regulation; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Immunoassay; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Phenotype; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Risk Assessment; Risk Factors; Venous Thrombosis; Vitamin B 12; Young Adult | 2010 |
Serum homocysteine in deep venous thrombosis, peripheral atherosclerosis and healthy Iranians: a case-control study.
Topics: Adult; Atherosclerosis; Case-Control Studies; Female; Homocysteine; Humans; Iran; Male; Middle Aged; Ultrasonography, Doppler, Duplex; Venous Thrombosis | 2009 |
Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Factor V; Female; Genetic Predisposition to Disease; Homocysteine; Humans; Male; Methylenetetrahydrofolate Dehydrogenase (NADP); Middle Aged; Mutation, Missense; Prothrombin; Thrombophlebitis; Varicose Veins; Venous Thrombosis | 2011 |
Hyperhomocysteinemia and the methylene tetrahydrofolate reductase C677T mutation in splanchnic vein thrombosis.
Topics: Adult; Cholesterol; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Multivariate Analysis; Mutation; Spain; Splanchnic Circulation; Venous Thrombosis | 2011 |
Extrahepatic portal vein thrombosis in children and adolescents: Influence of genetic thrombophilic disorders.
Topics: Adolescent; Case-Control Studies; Child; Homocysteine; Humans; Male; Portal Vein; Prospective Studies; Protein C; Protein S; Risk Factors; Thrombophilia; Venous Thrombosis | 2010 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
[Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and the MTHFR gene mutation].
Topics: Diagnosis, Differential; DNA Mutational Analysis; Factor V; Genetic Carrier Screening; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Homozygote; Humans; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Renal Veins; Thrombophilia; Venous Thrombosis | 2012 |
Portal vein thrombosis in inflammatory bowel diseases: a single-center case series.
Topics: Adult; Anticoagulants; Colitis, Ulcerative; Crohn Disease; Female; Homocysteine; Humans; Lupus Coagulation Inhibitor; Male; Middle Aged; Portal Vein; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thrombosis; von Willebrand Factor | 2012 |
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Topics: 3' Untranslated Regions; Activated Protein C Resistance; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; Codon; Factor V; Fasting; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation, Missense; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Poland; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Belgium; Case-Control Studies; Fasting; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Point Mutation; Prospective Studies; Protein C Deficiency; Pulmonary Embolism; Risk Factors; Thrombophilia; Venous Thrombosis | 2002 |
Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation Factor Inhibitors; Case-Control Studies; Comorbidity; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Multivariate Analysis; Myeloproliferative Disorders; Prevalence; Retrospective Studies; Splanchnic Circulation; Thrombophilia; Venous Thrombosis | 2003 |
Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).
Topics: Aged; Aging; Animals; Case-Control Studies; Cohort Studies; Factor V; Female; Genotype; Homocysteine; Humans; Longitudinal Studies; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prospective Studies; Risk Factors; Venous Thrombosis | 2003 |
Familial hyperhomocysteinemia: multiple venous thrombosis in four generations of a family.
Topics: Adult; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Nitroprusside; Pedigree; Venous Thrombosis; Vitamin B 12; Warfarin | 2003 |
Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N-acetylcysteine therapy.
Topics: Acetylcysteine; Fatal Outcome; Fibrinolytic Agents; Homocysteine; Humans; Male; Middle Aged; Pulmonary Embolism; Streptokinase; Thrombosis; Venous Thrombosis | 2003 |
Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease.
Topics: Adult; Behcet Syndrome; Female; Homocysteine; Homozygote; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Venous Thrombosis | 2003 |
A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities.
Topics: Adult; Arabs; Bahrain; Coronary Artery Disease; Female; Genetic Variation; Genetics, Population; Genotype; Homocysteine; Humans; Lebanon; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Venous Thrombosis | 2003 |
Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Female; Gene Frequency; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Retrospective Studies; Russia; Thrombosis; Venous Thrombosis | 2003 |
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.
Topics: Adult; Antithrombin III; Cerebral Veins; Factor V; Female; Homocysteine; Humans; Hyperhomocysteinemia; Intracranial Thrombosis; Male; Point Mutation; Prevalence; Protein C; Protein S; Prothrombin; Risk Factors; Thrombophilia; Venous Thrombosis | 2004 |
[Hyperhomocysteinemia and deep-vein thrombosis].
Topics: Adult; Aged; Aged, 80 and over; Female; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Restriction Fragment Length; Venous Thrombosis; Vitamin B 12 | 2003 |
Increased coagulation factor levels leading to allograft renal vein thrombosis.
Topics: Blood Coagulation Factors; Factor IX; Factor VII; Factor VIII; Factor XI; Graft Rejection; Graft Survival; Homocysteine; Humans; Kidney Transplantation; Male; Middle Aged; Renal Veins; Venous Thrombosis | 2004 |
The 894 G > T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels.
Topics: Case-Control Studies; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Molecular Epidemiology; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrosation; Odds Ratio; Polymorphism, Single Nucleotide; Recurrence; Risk; Venous Thrombosis | 2004 |
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study.
Topics: Adult; Case-Control Studies; Denmark; Female; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Myocardial Ischemia; Polymorphism, Genetic; Prospective Studies; Risk Factors; Venous Thrombosis | 2004 |
Effect of genetic variation in the human S-adenosylhomocysteine hydrolase gene on total homocysteine concentrations and risk of recurrent venous thrombosis.
Topics: Adenosylhomocysteinase; Base Composition; Case-Control Studies; Chromosome Mapping; DNA Mutational Analysis; Genetic Variation; Homocysteine; Humans; Risk; Venous Thrombosis | 2004 |
Recurrent cerebral venous and peripheral arterial thrombosis.
Topics: Adolescent; Cerebral Veins; Female; Femoral Artery; Homocysteine; Humans; Magnetic Resonance Angiography; Thrombophilia; Thrombosis; Venous Thrombosis | 2004 |
[Relationship of plasma homocysteine and folic acid levels and 5,10-methylenetetrahydrofolate reductase gene mutation with venous thromboembolism].
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Case-Control Studies; Female; Folic Acid; Genotype; Homocysteine; Humans; Male; Middle Aged; Mutation; Venous Thrombosis | 2004 |
Hyperhomocysteinemia and deep vein thrombosis in orthotopic heart transplantation: a case report.
Topics: Adult; Anticoagulants; Enoxaparin; Heart Transplantation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Treatment Outcome; Venous Thrombosis | 2004 |
Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behcet's disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Cohort Studies; Comorbidity; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Prevalence; Tunisia; Uveitis; Venous Thrombosis | 2004 |
Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.
Topics: Age Distribution; Aged; Analysis of Variance; Arteriovenous Shunt, Surgical; Cohort Studies; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Probability; Renal Dialysis; Retrospective Studies; Risk Assessment; Sex Distribution; Statistics, Nonparametric; Venous Thrombosis | 2004 |
Venous thrombosis in inflammatory bowel disease.
Topics: Blood Coagulation Disorders; Colitis, Ulcerative; Crohn Disease; Factor V; Homocysteine; Humans; Inflammatory Bowel Diseases; Mutation; Prothrombin; Risk Factors; Venous Thrombosis | 2005 |
Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis.
Topics: Adult; Aged; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Retrospective Studies; Risk Factors; Venous Thrombosis | 2005 |
Thrombophilia testing in patients with venous thrombosis.
Topics: Blood Coagulation Factor Inhibitors; Factor V; Genetic Markers; Genetic Testing; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Prothrombin; Recurrence; Thrombophilia; Venous Thrombosis | 2005 |
Low levels of vitamin B12 and venous thromboembolic disease in elderly men.
Topics: Age Factors; Aged; Biomarkers; Case-Control Studies; Creatinine; Female; Folic Acid; Homocysteine; Humans; Logistic Models; Male; Risk Assessment; Thromboembolism; Venous Thrombosis; Vitamin B 12; Vitamin B Deficiency | 2005 |
[Hyperhomocysteine like thrombocytic risk factor in patient with systemic lupus erythematous with antiphospholipid syndrome].
Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Argentina; Female; Homocysteine; Humans; Hyperhomocysteinemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors; Thrombosis; Venous Thrombosis | 2005 |
Hereditary thrombophilia in ethnic Omani patients.
Topics: Adolescent; Adult; Aged; Blood Coagulation Disorders, Inherited; Blood Proteins; Case-Control Studies; Child; DNA Mutational Analysis; Female; Homocysteine; Humans; Male; Middle Aged; Oman; Pulmonary Embolism; Thrombophilia; Thrombosis; Venous Thrombosis | 2006 |
No added value of the methionine loading task in assessment for venous thrombosis and cardiovascular disease risk.
Topics: Aged; Cardiovascular Diseases; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Middle Aged; Practice Guidelines as Topic; Risk; ROC Curve; Venous Thrombosis | 2006 |
A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATROS (Brazilian Thrombosis Study).
Topics: Adolescent; Adult; Aged; Brazil; Child; Child, Preschool; DNA Mutational Analysis; Female; Genotype; Homocysteine; Humans; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Risk; Transcobalamins; Venous Thrombosis | 2007 |
The FIELD study.
Topics: Diabetes Mellitus, Type 2; Fenofibrate; Homocysteine; Humans; Hypolipidemic Agents; Risk Factors; Venous Thrombosis | 2006 |
Low fasting methionine concentration as a novel risk factor for recurrent venous thrombosis.
Topics: Adult; Aged; Case-Control Studies; Cysteine; Fasting; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methionine; Methylation; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Risk Assessment; Risk Factors; Venous Thrombosis | 2006 |
Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Creatinine; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Leg; Male; Middle Aged; Prevalence; Recurrence; Tunisia; Venous Thrombosis; Vitamin B 12 | 2007 |
Plasma homocysteine and hematological factors in patients with venous thromboembolic diseases in Kuwait.
Topics: Activated Protein C Resistance; Adult; Creatinine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Kuwait; Male; Protein C; Protein S; Thromboembolism; Venous Thrombosis | 2007 |
Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Cohort Studies; Fasting; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Incidence; Male; Methionine; Middle Aged; Netherlands; Predictive Value of Tests; Retrospective Studies; Risk Assessment; Risk Factors; Thrombosis; Time Factors; Venous Thrombosis | 2007 |
Endogenous risk factors for deep-vein thrombosis in patients with acute spinal cord injuries.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Female; Follow-Up Studies; Homocysteine; Humans; Incidence; Italy; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Prognosis; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Spinal Cord Injuries; Treatment Outcome; Venous Thrombosis | 2007 |
Plasma homocysteine cutoff values for venous thrombosis.
Topics: Adult; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Venous Thrombosis | 2007 |
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
Topics: Adolescent; Adult; Aged; Alleles; Biomarkers; DNA; Factor V; Female; Follow-Up Studies; Genotype; Homocysteine; Humans; Incidence; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Netherlands; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Prothrombin; Pulmonary Embolism; Retrospective Studies; Risk Factors; Surveys and Questionnaires; Venous Thrombosis | 2007 |
Inherited risk factors for deep venous thrombosis following total hip arthroplasty in Japanese patients: matched control study.
Topics: Aged; Arthroplasty, Replacement, Hip; Case-Control Studies; Factor V; Female; Homocysteine; Humans; Male; Middle Aged; Polymorphism, Genetic; Postoperative Complications; Protein C; Risk Factors; Venous Thrombosis | 2007 |
Associations of common polymorphisms in the thymidylate synthase, reduced folate carrier and 5-aminoimidazole-4-carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase genes with folate and homocysteine levels and venous thrombosis
Topics: Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Hydroxymethyl and Formyl Transferases; Membrane Transport Proteins; Multienzyme Complexes; Nucleotide Deaminases; Polymorphism, Genetic; Reduced Folate Carrier Protein; Thymidylate Synthase; Venous Thrombosis | 2007 |
Vitamin supplementation in the secondary prevention of venous thromboembolism: about the VITRO study.
Topics: Clinical Trials as Topic; Dietary Supplements; Homocysteine; Humans; Thrombophilia; Venous Thrombosis; Vitamins | 2007 |
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study.
Topics: Aged; Case-Control Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Metabolic Syndrome; Middle Aged; Odds Ratio; Prevalence; Risk Factors; Venous Thrombosis | 2007 |
Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Adult; Aged; Alleles; Base Sequence; Case-Control Studies; Cohort Studies; Female; Ferredoxin-NADP Reductase; Genotype; Heterozygote; Homocysteine; Humans; India; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Risk Factors; Venous Thrombosis | 2008 |
Catechol-O-methyltransferase genotype is associated with plasma total homocysteine levels and may increase venous thrombosis risk.
Topics: Adult; Aged; Case-Control Studies; Catechol O-Methyltransferase; Female; Gene Frequency; Genotype; Haplotypes; Homocysteine; Humans; Linkage Disequilibrium; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Recurrence; Risk Assessment; Risk Factors; Venous Thrombosis | 2007 |
Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population--results from the HUNT 2 study.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Epidemiologic Methods; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Pulmonary Embolism; Venous Thrombosis | 2008 |
Thymidylate synthase genotype and serum concentrations of homocysteine and folate in Behçet's disease.
Topics: Adolescent; Adult; Behcet Syndrome; Case-Control Studies; Female; Folic Acid; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Middle Aged; Promoter Regions, Genetic; Tandem Repeat Sequences; Thymidylate Synthase; Venous Thrombosis; Young Adult | 2008 |
[Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine].
Topics: Adult; Aged; Antithrombin III; Chromatography, Ion Exchange; Data Interpretation, Statistical; Female; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Protein C; Protein S; Risk Factors; Serine Proteinase Inhibitors; Surveys and Questionnaires; Venous Thrombosis | 1998 |
Venous thrombosis and hyperhomocysteinaemia.
Topics: Adult; Anticoagulants; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Recurrence; Risk Factors; Venous Thrombosis; Vitamin B 12 | 1998 |
Mild hyperhomocysteinemia and MTHFR C677T do not increase the risk for venous thrombosis in a Spanish population.
Topics: Adult; Female; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Risk Factors; Spain; Venous Thrombosis | 1998 |
Plasma homocysteine determined by capillary electrophoresis with laser-induced fluorescence detection.
Topics: Coronary Disease; Electrophoresis, Capillary; Fluorescence; Homocysteine; Humans; Lasers; Reproducibility of Results; Venous Thrombosis | 1999 |
[A young patient with chronic recurrent leg ulcers; hyperhomocysteinemia and heterozygote for factor V Leiden].
Topics: Adult; Anticoagulants; Bandages; Chronic Disease; Factor V; Folic Acid; Genetic Carrier Screening; Genetic Predisposition to Disease; Homocysteine; Humans; Leg Ulcer; Male; Metabolism, Inborn Errors; Secondary Prevention; Venous Thrombosis | 1998 |
Thrombosis in a patient with combined homozygosity for the factor V Leiden mutation and a mutation in the 3'-untranslated region of the prothrombin gene.
Topics: 3' Untranslated Regions; Adolescent; Antithrombins; Blood Coagulation Factor Inhibitors; Blood Coagulation Tests; Factor V; Female; Heterozygote; Homocysteine; Homozygote; Humans; Male; Middle Aged; Mutation; Nuclear Family; Prothrombin; Saphenous Vein; Venous Thrombosis; Warfarin | 1999 |
Thermolabile methyltetrahydrofolate reductase associated with unusual venous and arterial thromboses.
Topics: Adult; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Thrombosis; Venous Thrombosis | 1999 |
[Obstetric problems followed by stroke].
Topics: Abortion, Habitual; Adult; Arteriosclerosis; Cerebral Infarction; Diagnosis, Differential; Female; Fetal Death; Folic Acid; Folic Acid Deficiency; Homocysteine; Humans; Hyperhomocysteinemia; Infant, Newborn; Male; Methionine; Nutrition Disorders; Placental Insufficiency; Pregnancy; Pregnancy Complications, Cardiovascular; Pyridoxine; Smoking; Venous Thrombosis; Vitamin B 6 Deficiency | 1999 |
Genetic determinants of heritable venous thrombosis: genotyping methods for factor V(Leiden)A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations.
Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Algorithms; Base Sequence; DNA Primers; Factor V; Genetic Predisposition to Disease; Homocysteine; Humans; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oxidoreductases; Polymerase Chain Reaction; Prothrombin; Venous Thrombosis | 1999 |
Gas chromatographic-mass spectrometric determination of total homocysteine in human plasma by stable isotope dilution: method and clinical applications.
Topics: Adult; Calibration; Case-Control Studies; Cerebrovascular Disorders; Female; Gas Chromatography-Mass Spectrometry; Homocysteine; Humans; Isotopes; Male; Middle Aged; Reference Values; Reproducibility of Results; Venous Thrombosis | 1999 |
Hyperhomocysteinaemia and upper extremity deep venous thrombosis: a case report.
Topics: Adult; Aerospace Medicine; Axillary Vein; Causality; Dehydration; Disability Evaluation; Homocysteine; Humans; Hyperhomocysteinemia; Male; Military Personnel; Occupational Diseases; Physical Exertion; Recurrence; South Australia; Subclavian Vein; Ultrasonography; Venous Thrombosis | 1999 |
Ocular venous occlusion and hyperhomocysteinemia.
Topics: Homocysteine; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Retinal Vein; Venous Thrombosis | 1999 |
Validation of an immunoassay for measurement of plasma total homocysteine.
Topics: Autoanalysis; Bilirubin; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Fluorescence Polarization Immunoassay; Freezing; Homocysteine; Humans; Quality Control; Renal Insufficiency; Risk Factors; Sensitivity and Specificity; Smoking; Triglycerides; Venous Thrombosis | 1999 |
The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
Topics: Adolescent; Age of Onset; Alleles; Case-Control Studies; Child; Child, Preschool; Factor V; Female; Genetic Predisposition to Disease; Genotype; Germany; Homocysteine; Humans; Hyperhomocysteinemia; Infant; Infant, Newborn; Male; Methylenetetrahydrofolate Reductase (NADPH2); Multifactorial Inheritance; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Prothrombin; Risk Factors; Statistics, Nonparametric; Venous Thrombosis | 1999 |
Deep venous thrombosis as the presenting feature in a patient with coeliac disease and homocysteinaemia.
Topics: Adult; Celiac Disease; Folic Acid Deficiency; Homocysteine; Humans; Male; Recurrence; Venous Thrombosis | 1999 |
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
Topics: Antibodies, Anticardiolipin; Antithrombins; Budd-Chiari Syndrome; Case-Control Studies; Confidence Intervals; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Infant; Infant, Newborn; Lipoprotein(a); Male; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Portal Vein; Prospective Studies; Protein C; Protein S; Prothrombin; Renal Veins; Venous Thrombosis | 2000 |
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Coronary Disease; Fasting; Female; Fluorometry; Genotype; Homocysteine; Humans; Male; Methionine; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prevalence; Venous Thrombosis | 2001 |
Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
Topics: Adult; Aged; Case-Control Studies; Factor V; Female; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Prevalence; Risk Factors; Taiwan; Thromboembolism; Thrombophilia; Venous Thrombosis | 2001 |
The role of cysteine and homocysteine in venous and arterial thrombotic disease.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Cysteine; Fasting; Female; Homocysteine; Humans; Male; Methionine; Middle Aged; Myocardial Infarction; Reference Values; Thrombosis; Venous Thrombosis | 2001 |
Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis.
Topics: Adolescent; Adult; Aged; Child; Fasting; Female; Folic Acid; Homocysteine; Humans; Male; Methionine; Middle Aged; Risk Factors; Venous Thrombosis; Vitamin B 12; Vitamin B 6 | 2001 |
Comparative prevalence of antiphospholipid antibodies and thrombophilic genotypes in consecutive patients with venous thrombosis.
Topics: Adult; Age of Onset; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Genotype; Homocysteine; Humans; Male; Prevalence; Risk Factors; Thrombophilia; Venous Thrombosis | 2001 |
Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke.
Topics: Adult; Brain Ischemia; Factor V; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Prothrombin; Risk Factors; Stroke; Venous Thrombosis | 2002 |
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis.
Topics: Adolescent; Adult; Age Factors; Aged; Anticoagulants; C-Reactive Protein; Case-Control Studies; Factor VIII; Female; Homocysteine; Humans; Interleukin-8; Male; Middle Aged; Odds Ratio; Risk; Risk Factors; Sex Factors; Venous Thrombosis | 2002 |
Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study.
Topics: Adult; Aged; Case-Control Studies; Erythrocytes; Female; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Pulmonary Embolism; Risk Factors; Tetrahydrofolates; Venous Thrombosis | 2002 |
Homocysteine and vascular access thrombosis in hemodialysis patients.
Topics: Adult; Aged; Arteriovenous Fistula; Catheters, Indwelling; Female; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Risk Factors; Time Factors; Venous Thrombosis | 2002 |